Diltiazem for clozapine-induced generalized hyperhidrosis
Background Clozapine can be associated with significant side effects and tolerability issues. Hyperhidrosis occurs less commonly and is unanticipated by clinicians because of clozapine's significant anticholinergic activity. Case Report A 34-year-old female developed clozapine-induced nocturnal...
Main Authors: | Kenton Emma M. PharmD, Zoellner Samantha M. PharmD Candidate, May 2024, Nelson Leigh Anne PharmD, BCPP |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association of Psychiatric Pharmacists
2023-08-01
|
Series: | Mental Health Clinician |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2023.08.193 |
Similar Items
-
Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01) -
Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid
by: Ranel Troy Santos, PharmD, BCPP, et al.
Published: (2023-01-01) -
Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01) -
Impact of COVID-19 quarantines on clozapine-induced constipation: Experience of utilizing a clozapine-induced constipation protocol at a state forensic psychiatric facility
by: Bridgette M. Gleisner, PharmD, et al.
Published: (2024-02-01) -
A case report on the effects of COVID-19 on ANC monitoring in a patient on long-term clozapine treatment
by: Denton Lauren PharmD, et al.
Published: (2023-08-01)